Index Note: Page numbers of article titles are in boldface type. A ACHD. See Adult congenital heart disease (ACHD) Adult congenital heart disease (ACHD), 503 512 across life span prevalence of, 504 506 arrhythmias in, 571 588 (See also Arrhythmia(s), in ACHD) burden of, 506 507 distribution of gender differences in, 504 505 future directions in, 510 health care quality in current efforts, 638 639, 635 641 future directions in, 639 640 heart failure in, 589 598 (See also Heart failure, in ACHD) impact on health services utilization, 507 508 incidence of, 504 introduction, 503, 625 specialized care in, 508 509 delivering of, 509 510 mortality data, 505 506, 508 outcomes of gender differences in, 504 505 population size of, 506 pregnancy and, 611 623 (See also Pregnancy, ACHD and) prevalence of, 506 across life span, 504 506 birth-related, 504 psychosocial issues related to, 625 634 biopsychosocial challenges, 627 clinical strategies in optimizing, 630 demographic factors, 629 European outcomes, 628 629 medical factors, 629 630 psychological distress, 629 630 psychologic functioning, 627, 628 social functioning, 627 629 quality of life effects of, 508 survival shifts in, 505 506 transition to, 625 634 from pediatric to adult care, 625 627 AF. See Atrial fibrillation (AF) Anesthesia/anesthetics in pregnancy-related ACHD, 620 621 Cardiol Clin 33 (2015) 643 647 http://dx.doi.org/10.1016/s0733-8651(15)00100-9 0733-8651/15/$ see front matter Ó 2015 Elsevier Inc. All rights reserved. Aneurysm(s) after CoA management, 527 Antibiotics prevention during pregnancy, 621 Aorta coarctation of, 521 530 (See also Coarctation of aorta (CoA)) Aortic root dilation TOF and, 537 Arrhythmia(s), 571 588 ICDs-related sudden cardiac death and introduction, 571 572, 575 582 atrial arrhythmias, 575 577 catheter ablation in, 578 580 device therapy in, 580 581 surgical, 580 ventricular arrhythmias, 577 tachycardia, 572 575 (See also Tachycardia(s), ) decreased cardiac output and, 561 563 D-TGA and, 548 549 TOF and, 536 537 Arterial switch in D-TGA evaluation, 551 553 in D-TGA management, 550, 554 556 anatomic complications of, 550 551 Arterial switch operation (ASO) defined, 544 ASD. See Atrial septal defect (ASD) ASO. See Arterial switch operation (ASO) Atrial arrhythmias, 575 577 catheter ablation in, 579 580 thromboprophylaxis of, 577 578 Atrial fibrillation (AF), 574 catheter ablation in, 580 Atrial septal defect (ASD), 513 516 clinical presentation of, 514 515 described, 513 514 cardiology.theclinics.com
644 Index Atrial (continued ) indications for, 515 late, 515 516 pathophysiology of, 514 pregnancy and, 516 Atrial switch in D-TGA evaluation, 551 553 in D-TGA management, 549 550, 553 555 anatomic complications of, 549 550 Atrioventricular (AV) node dysfunction AV. See Atrioventricular (AV) B Bedside tests congenital heart disease, 600 602 Blalock-Hanlon technique Bradyarrhythmia(s) C Cardiac catheterization in CoA evaluation, 526 Cardiac magnetic resonance imaging (cmri) in CoA evaluation, 524 525 Cardiac output decreased causes of, 561 563 potential outcomes of, 561 563 Catheter ablation of arrhythmias, 578 580 CHD. See Congenital heart disease (CHD) Chest radiography cmri. See Cardiac magnetic resonance imaging (cmri) CoA. See Coarctation of aorta (CoA) Coarctation of aorta (CoA), 521 530 cause of, 521 522 clinical presentation of, 523 congenital heart lesions associated with, 522 diagnostic, 523 526 cardiac catheterization in, 526 cmri in, 524 525 CT in, 525 526 introduction, 521 indications for, 526 long-term complications of, 527 528 surgical and transcatheter therapies in, 526 527 noncardiac associations with, 522 523 pathogenesis of, 521 522 Complete transposition of great arteries, 544 Computed tomography (CT) in CoA evaluation, 525 526 in D-TGA evaluation, 553 Congenital heart disease (CHD) adult (See Adult congenital heart disease (ACHD)) pulmonary hypertension in, 599 609 (See also Pulmonary hypertension, in congenital heart disease) Congenital heart lesions Congenitally corrected transposition of great arteries (TGA), 544 545 Coronary artery stenosis D-TGA and, 550 CT. See Computed tomography (CT) Cyanosis 564 D Dextro-transposition of great arteries (D-TGA), 543 558 anatomical complications of, 549 551 arterial switch, 550 atrial switch, 549 550 coronary artery stenosis, 550 neo-aortic root dilation, 550 551 pulmonary artery stenosis, 551 electrophysiology of, 555 chest radiograph in, 552 CT in, 553 echocardiography in, 552 553 EKG in, 552 MRI in, 553 physical examination in, 551 552 rhythm monitors in, 552 stress testing in, 552 arrhythmias, 548 549 heart failure, 547 548 survival data, 547 catheter-based intervention in, 554 555 clinical, 551 553 medical, 553 554 surgical, 555 556 overview of, 543 pregnancy and, 554 surgical palliation of, 545 547 ASO in, 545 Blalock-Hanlon technique in, 545
Index 645 Mustard/Senning operation in, 545 Mustard/Senning takedown with arterial switch in, 545 547 pulmonary artery band in, 547 Rashkind technique in, 545 terminology related to, 543 545 D-TGA. See Dextro-transposition of great arteries (D-TGA) E Ebstein anomaly pregnancy effects of, 617 Echocardiography 553 congenital heart disease, 602 EKG. See Electrocardiogram (EKG) Electrocardiogram (EKG) F Fontan circulation pregnancy effects of, 619 pulmonary vascular disease in patients with, 605 606 Fontan operation, 559 569 anatomic and physiologic considerations of, 560 561 decreased cardiac output after causes and potential treatment for, 561 563 extracardiac organ system interaction after, 565 566 introduction, 559 liver disease after, 565 long-term survival after, 561 mechanical assist devices after, 566 mortality data, 561 PLE after, 563 565 pulmonary complications of, 565 566 thromboembolic complications of, 565 transplantation after, 566 G Gender as factor, 504 505 Great arteries dextro-transposition of (See Dextro-transposition of great arteries (D-TGA)) H Health care quality, 635 641 (See also Adult congenital heart disease (ACHD), health care quality in) Heart disease(s) congenital adult (See Adult congenital heart disease (ACHD)) Heart failure, 589 598 invasive hemodynamic, 590 592 arrhythmia interventions in, 592 593 palliative care in, 595 surgical, 593 595 transcatheter interventions in, 590 592 understanding of, 589 590 D-TGA and, 547 548 in TOF, 537 Heart lesions congenital Hemodynamics invasive congenital heart disease, 602 Hypertension pulmonary in congenital heart disease, 599 609 (See also Pulmonary hypertension, in congenital heart disease) systolic arterial after CoA management, 527 528 I ICDs. See Implantable cardiac defibrillators (ICDs) Implantable cardiac defibrillators (ICDs) sudden cardiac death related to Intra-atrial reentry tachycardia, 572 574 L Left heart in TOF, 537 Left heart outflow obstructions pregnancy effects of, 616 617 Left ventricular dysfunction TOF and, 537 Lesion(s). See also specific types congenital heart mechanical shunt, 513 520 (See also Shunt lesions) structural Liver disease Fontan operation and, 565
646 Index M Magnetic resonance imaging (MRI) cardiac in CoA evaluation, 524 525 in D-TGA evaluation, 553 Marfan syndrome pregnancy effects of, 619 620 Mechanical assist devices after Fontan operation, 566 Mechanical lesions MRI. See Magnetic resonance imaging (MRI) Mustard operation defined, 544 Mustard/Senning operation Mustard/Senning takedown with arterial switch 547 N Neo-aortic root dilation D-TGA and, 550 551 P Patent ductus arteriosus (PDA), 518 519 clinical presentation of, 518 519 described, 518 indications for, 519 late, 519 pathophysiology of, 518 pregnancy and, 519 PDA. See Patent ductus arteriosus (PDA) PLE. See Protein losing enteropathy (PLE) Pregnancy ACHD and, 611 623 anesthesia in, 620 621 congenital heart diagnoses, 615 620 Ebstein anomaly, 617 Fontan circulation, 619 left heart outflow obstructions, 616 617 Marfan syndrome, 619 620 shunt lesions, 615 616 TGA, 618 619 TOF, 617 delivery effects of, 620 621 introduction, 611 612 preconception counseling for, 613 614 preconception risk prediction related to, 614 616 prevention of antibiotic-related, 621 after TOF repair, 537 538 ASD and, 516 D-TGA and, 554 normal physiology of, 613 PDA and, 519 VSD and, 518 Protein losing enteropathy (PLE) Fontan operation and, 563 565 Pulmonary artery band in D-TGA palliation, 547 Pulmonary artery stenosis D-TGA and, 551 Pulmonary hypertension in congenital heart disease, 599 609 classification of, 600 clinical, 600 602 bedside tests in, 600 602 invasive hemodynamics in, 602 physical examination in, 600 602 6-minute walk test in, 600 602 demographics of, 599 600 introduction, 599 600 treatment of, 602 605 segmental, 606 in special populations, 605 606 Pulmonary system Fontan operation effects on, 565 566 Pulmonary valve replacement surgical vs. percutaneous approach to, 534 536 Pulmonary vascular disease in patients with Fontan circulation, 605 606 Pulmonary vascular resistance elevated decreased cardiac output and, 564 Q Quality defined, 635 636 Quality improvement, 636 637 Quality measure(s) reporting of, 637 Quality measurement, 636 637 Quality of life ACHD effects on, 508 R Radiography chest Rashkind technique Recoarctation after CoA management, 527 Residual pulmonary valve dysfunction in TOF management, 533 536 Rhythm monitors
Index 647 S Segmental pulmonary hypertension, 606 Senning operation Shunt lesions, 513 520 ASD, 513 516 introduction, 513 PDA, 518 519 pregnancy effects of, 615 616 VSD, 516 518 Single ventricle anatomy of, 559 560 epidemiology of, 559 560 physiology of, 559 560 Sinus node dysfunction (SND) 6-minute walk test congenital heart disease, 600 602 SND. See Sinus node dysfunction (SND) Stress test(s) Structural lesions Sudden cardiac death ICDs and risk factors for TOF and, 536 537 Supraventricular tachycardias, 572 catheter ablation in, 578 579 Systolic arterial hypertension after CoA management, 527 528 T Tachycardia(s), 572 575 AF, 574 bradyarrhythmias, 575 intra-atrial reentry tachycardia, 572 574 supraventricular tachycardias, 572 ventricular arrhythmias, 574 575 ventricular, 580 Tetralogy of Fallot (TOF), 531 541 anatomy related to, 531 532 arrhythmias associated with, 536 537 imaging in, 533 heart failure in, 537 introduction, 531 left heart in, 537 initial surgical repair in, 531 532 outpatient surveillance in general principles of, 532 533 pregnancy after, 537 538 residual pulmonary valve dysfunction management in, 533 536 pregnancy effects of, 617 repaired anatomic sequelae of, 532 sudden death related to, 536 537 TGA. See Transposition of great arteries (TAG) Thromboembolic system Fontan operation effects on, 565 TOF. See Tetralogy of Fallot (TOF) Transplantation after Fontan operation, 566 Transposition of great arteries (TGA) complete, 544 congenitally corrected, 544 545 dextro- (See Dextro-transposition of great arteries (D-TGA)) pregnancy effects of, 618 619 V Ventricular arrhythmias, 574 575 pharmacologic, 578 Ventricular dysfunction decreased cardiac output and, 564 Ventricular septal defect (VSD), 516 518 clinical presentation of, 517 described, 516 indications for, 517 late, 517 518 pathophysiology of, 516 517 pregnancy and, 518 Ventricular tachycardia catheter ablation in, 580 VSD. See Ventricular septal defect (VSD)